Search results
Results from the WOW.Com Content Network
Although the capital for private equity originally came from individual investors or corporations, in the 1970s, private equity became an asset class in which various institutional investors allocated capital in the hopes of achieving risk-adjusted returns that exceed those possible in the public equity markets. In the 1980s, insurers were ...
The general partner is the financial entity used to control and manage the fund, while the limited partners are the individual investors who receive their return as capital interest. [1] Private equity funds and hedge funds are private investment vehicles used to pool investment capital, usually for a small group of large institutional or ...
Vivo has three strategies, Private equity, Public equity and Venture capital. Vivo historically has invested 70% of its capital into biotechnology companies and 30% into medical device companies. Originally it started investing in early stage companies but later on more towards growth stage companies and buyout deals. In the early 2000s, it ...
Ares Management Corporation is a global alternative investment manager operating in the credit, private equity and real estate markets. The company was founded in 1997 with additional offices across North America, Europe, and Asia.
In 2016, LGP closed Green Equity Investors VII, L.P. ("GEI VII"), with $9.6 billion of committed capital. [29] In 2019, LGP raised $14.75 billion for two new funds. [15] In February 2021, ProPublica reported on a dispute between LGP and Rhode Island's regulators and legislators over LGP's divestment in Prospect Medical Holdings.
Boyu Capital (Boyu; Chinese: 博裕資本; pinyin: Bóyù Zīběn) is a Chinese private equity firm headquartered in Hong Kong with additional offices in Beijing, Shanghai and Singapore. [ 2 ] [ 3 ] The firm has gained a reputation as a Princeling -affiliated firm as one of its co-founders, Alvin Jiang, is grandson of Jiang Zemin , the ...
Aldrich left RA Capital in 2009 to start Longwood Fund, a venture capital firm although he still remains an investor in RA Capital. [4] In 2009, RA Capital assets fell by 35.3% due to its large investment in Sequenom which lost 90% of its market value after it admitted it had falsified data on its tests for Down syndrome treatment. As a result ...